Concepedia

Myriam Rochdi

MR

8

Publications

1.2K

Citations

8

H-Index

1992

Active since

Affiliations

University of California San Diego(Current)

Inserm

Hôpital Fernand-Widal

Myriam Rochdi is an author at University of California San Diego specializing in medicine, pharmacology, and drug resistance.

Top concepts

Publications per year

1992–2004

8

Publications

8

Increased Expression of the Copper Efflux Transporter ATP7A Mediates Resistance to Cisplatin, Carboplatin, and Oxaliplatin in Ovarian Cancer Cells

Goli Samimi, Roohangiz Safaei, Kuniyuki Katano et al. · Clinical Cancer Research · 2004 · 373 citations · Full text

Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper.

Kuniyuki Katano, Akira Kondo, Roohangiz Safaei et al. · PubMed · 2002 · 294 citations

, , +17

The Copper Export Pump ATP7B Modulates the Cellular Pharmacology of Carboplatin in Ovarian Carcinoma Cells

Kuniyuki Katano, Roohangiz Safaei, Goli Samimi et al. · Molecular Pharmacology · 2003 · 125 citations

Pharmacokinetics and absolute bioavailability of colchicine after i. v. and oral administration in healthy human volunteers and elderly subjects

Myriam Rochdi, A. Sabouraud, C. Girre et al. · European Journal of Clinical Pharmacology · 1994 · 121 citations

, , +6

Oral Absorption Characteristics and Pharmacokinetics of Colchicine in Healthy Volunteers after Single and Multiple Doses

Géraldine M. Ferron, Myriam Rochdi, William J. Jusko et al. · The Journal of Clinical Pharmacology · 1996 · 107 citations

Rows per page

1–5 of 8